Logo image of 1MYCR.MI

MYCRONIC AB (1MYCR.MI) Stock Fundamental Analysis

BIT:1MYCR - Euronext Milan - SE0025158629 - Common Stock - Currency: EUR

18.706  -0.28 (-1.47%)

Fundamental Rating

7

1MYCR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 53 industry peers in the Electronic Equipment, Instruments & Components industry. 1MYCR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1MYCR has a correct valuation and a medium growth rate. With these ratings, 1MYCR could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

1MYCR had positive earnings in the past year.
1MYCR had a positive operating cash flow in the past year.
Each year in the past 5 years 1MYCR has been profitable.
In the past 5 years 1MYCR always reported a positive cash flow from operatings.
1MYCR.MI Yearly Net Income VS EBIT VS OCF VS FCF1MYCR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 19.07%, 1MYCR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 29.29%, 1MYCR belongs to the best of the industry, outperforming 98.11% of the companies in the same industry.
The Return On Invested Capital of 1MYCR (25.44%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1MYCR is significantly above the industry average of 7.71%.
The last Return On Invested Capital (25.44%) for 1MYCR is above the 3 year average (17.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.07%
ROE 29.29%
ROIC 25.44%
ROA(3y)12.74%
ROA(5y)12.95%
ROE(3y)20.23%
ROE(5y)20.45%
ROIC(3y)17.55%
ROIC(5y)18.22%
1MYCR.MI Yearly ROA, ROE, ROIC1MYCR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

1MYCR has a Profit Margin of 24.53%. This is amongst the best in the industry. 1MYCR outperforms 98.11% of its industry peers.
In the last couple of years the Profit Margin of 1MYCR has grown nicely.
1MYCR's Operating Margin of 30.15% is amongst the best of the industry. 1MYCR outperforms 100.00% of its industry peers.
1MYCR's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 54.49%, 1MYCR is doing good in the industry, outperforming 66.04% of the companies in the same industry.
In the last couple of years the Gross Margin of 1MYCR has remained more or less at the same level.
Industry RankSector Rank
OM 30.15%
PM (TTM) 24.53%
GM 54.49%
OM growth 3Y8.18%
OM growth 5Y1.8%
PM growth 3Y10.11%
PM growth 5Y3.74%
GM growth 3Y1.84%
GM growth 5Y-1.09%
1MYCR.MI Yearly Profit, Operating, Gross Margins1MYCR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

1MYCR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1MYCR has about the same amount of shares outstanding.
1MYCR has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for 1MYCR has been reduced compared to a year ago.
1MYCR.MI Yearly Shares Outstanding1MYCR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
1MYCR.MI Yearly Total Debt VS Total Assets1MYCR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

1MYCR has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
The Debt to FCF ratio of 1MYCR (0.14) is better than 96.23% of its industry peers.
1MYCR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of 1MYCR (0.02) is better than 90.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.14
Altman-Z N/A
ROIC/WACC3.71
WACC6.86%
1MYCR.MI Yearly LT Debt VS Equity VS FCF1MYCR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

1MYCR has a Current Ratio of 2.16. This indicates that 1MYCR is financially healthy and has no problem in meeting its short term obligations.
1MYCR's Current ratio of 2.16 is fine compared to the rest of the industry. 1MYCR outperforms 71.70% of its industry peers.
A Quick Ratio of 1.38 indicates that 1MYCR should not have too much problems paying its short term obligations.
1MYCR has a Quick ratio of 1.38. This is in the better half of the industry: 1MYCR outperforms 67.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.38
1MYCR.MI Yearly Current Assets VS Current Liabilites1MYCR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

6

3. Growth

3.1 Past

1MYCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.35%, which is quite impressive.
The Earnings Per Share has been growing by 14.42% on average over the past years. This is quite good.
The Revenue has grown by 24.53% in the past year. This is a very strong growth!
The Revenue has been growing by 10.38% on average over the past years. This is quite good.
EPS 1Y (TTM)32.35%
EPS 3Y26.73%
EPS 5Y14.42%
EPS Q2Q%55.1%
Revenue 1Y (TTM)24.53%
Revenue growth 3Y15.04%
Revenue growth 5Y10.38%
Sales Q2Q%35.3%

3.2 Future

Based on estimates for the next years, 1MYCR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.69% on average per year.
The Revenue is expected to grow by 6.12% on average over the next years.
EPS Next Y0.15%
EPS Next 2Y20.57%
EPS Next 3Y19.69%
EPS Next 5YN/A
Revenue Next Year8.19%
Revenue Next 2Y7.65%
Revenue Next 3Y6.12%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1MYCR.MI Yearly Revenue VS Estimates1MYCR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
1MYCR.MI Yearly EPS VS Estimates1MYCR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

1MYCR is valuated rather expensively with a Price/Earnings ratio of 20.56.
Based on the Price/Earnings ratio, 1MYCR is valued a bit cheaper than the industry average as 73.58% of the companies are valued more expensively.
1MYCR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.82.
A Price/Forward Earnings ratio of 16.66 indicates a correct valuation of 1MYCR.
1MYCR's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of 1MYCR to the average of the S&P500 Index (36.21), we can say 1MYCR is valued rather cheaply.
Industry RankSector Rank
PE 20.56
Fwd PE 16.66
1MYCR.MI Price Earnings VS Forward Price Earnings1MYCR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1MYCR is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1MYCR.
Industry RankSector Rank
P/FCF 28.72
EV/EBITDA 14.59
1MYCR.MI Per share data1MYCR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 1MYCR may justify a higher PE ratio.
A more expensive valuation may be justified as 1MYCR's earnings are expected to grow with 19.69% in the coming years.
PEG (NY)136.04
PEG (5Y)1.43
EPS Next 2Y20.57%
EPS Next 3Y19.69%

2

5. Dividend

5.1 Amount

1MYCR has a Yearly Dividend Yield of 1.29%.
Compared to an average industry Dividend Yield of 2.86, 1MYCR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, 1MYCR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of 1MYCR decreases each year by -5.59%.
Dividend Growth(5Y)-5.59%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y20.57%
EPS Next 3Y19.69%
1MYCR.MI Yearly Income VS Free CF VS Dividend1MYCR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

MYCRONIC AB

BIT:1MYCR (7/22/2025, 7:00:00 PM)

18.706

-0.28 (-1.47%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-11 2025-07-11/bmo
Earnings (Next)10-23 2025-10-23
Inst Owners56.73%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap3.66B
Analysts84
Price Target23.1 (23.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend0.2
Dividend Growth(5Y)-5.59%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.64%
Min EPS beat(2)-1.09%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)18.71%
Min EPS beat(4)-1.09%
Max EPS beat(4)48.96%
EPS beat(8)5
Avg EPS beat(8)9.09%
EPS beat(12)6
Avg EPS beat(12)0.54%
EPS beat(16)7
Avg EPS beat(16)-3.02%
Revenue beat(2)2
Avg Revenue beat(2)4.25%
Min Revenue beat(2)1.52%
Max Revenue beat(2)6.99%
Revenue beat(4)4
Avg Revenue beat(4)7.99%
Min Revenue beat(4)1.52%
Max Revenue beat(4)12.76%
Revenue beat(8)5
Avg Revenue beat(8)4.08%
Revenue beat(12)6
Avg Revenue beat(12)1.43%
Revenue beat(16)7
Avg Revenue beat(16)0.23%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.56
Fwd PE 16.66
P/S 5.08
P/FCF 28.72
P/OCF 28.72
P/B 6.07
P/tB 13.37
EV/EBITDA 14.59
EPS(TTM)0.91
EY4.86%
EPS(NY)1.12
Fwd EY6%
FCF(TTM)0.65
FCFY3.48%
OCF(TTM)0.65
OCFY3.48%
SpS3.68
BVpS3.08
TBVpS1.4
PEG (NY)136.04
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 19.07%
ROE 29.29%
ROCE 31.82%
ROIC 25.44%
ROICexc 33.33%
ROICexgc 90.77%
OM 30.15%
PM (TTM) 24.53%
GM 54.49%
FCFM 17.69%
ROA(3y)12.74%
ROA(5y)12.95%
ROE(3y)20.23%
ROE(5y)20.45%
ROIC(3y)17.55%
ROIC(5y)18.22%
ROICexc(3y)27.62%
ROICexc(5y)26.94%
ROICexgc(3y)73.6%
ROICexgc(5y)66.48%
ROCE(3y)21.95%
ROCE(5y)22.79%
ROICexcg growth 3Y26.48%
ROICexcg growth 5Y12.04%
ROICexc growth 3Y21.26%
ROICexc growth 5Y4.04%
OM growth 3Y8.18%
OM growth 5Y1.8%
PM growth 3Y10.11%
PM growth 5Y3.74%
GM growth 3Y1.84%
GM growth 5Y-1.09%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.14
Debt/EBITDA 0.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 52.86%
Profit Quality 72.09%
Current Ratio 2.16
Quick Ratio 1.38
Altman-Z N/A
F-Score7
WACC6.86%
ROIC/WACC3.71
Cap/Depr(3y)72.64%
Cap/Depr(5y)64.98%
Cap/Sales(3y)3.16%
Cap/Sales(5y)2.98%
Profit Quality(3y)111.73%
Profit Quality(5y)117.31%
High Growth Momentum
Growth
EPS 1Y (TTM)32.35%
EPS 3Y26.73%
EPS 5Y14.42%
EPS Q2Q%55.1%
EPS Next Y0.15%
EPS Next 2Y20.57%
EPS Next 3Y19.69%
EPS Next 5YN/A
Revenue 1Y (TTM)24.53%
Revenue growth 3Y15.04%
Revenue growth 5Y10.38%
Sales Q2Q%35.3%
Revenue Next Year8.19%
Revenue Next 2Y7.65%
Revenue Next 3Y6.12%
Revenue Next 5YN/A
EBIT growth 1Y32.57%
EBIT growth 3Y24.46%
EBIT growth 5Y12.37%
EBIT Next Year19.75%
EBIT Next 3Y10.6%
EBIT Next 5YN/A
FCF growth 1Y-1.25%
FCF growth 3Y22.09%
FCF growth 5Y33.01%
OCF growth 1Y-1.25%
OCF growth 3Y23.74%
OCF growth 5Y28.02%